Download Files:
Products Details
Product Description
– Coblopasvir (KW-136) is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir can be used for research of chronic hepatitis C virus infection[1].
Web ID
– HY-117411
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C41H50N8O8
References
– [1]Gao Y, et al. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial. Liver Int. 2020;40(11):2685-2693.
CAS Number
– 1312608-46-0
Molecular Weight
– 782.88
SMILES
– O=C(N[C@H](C(N1[C@@H](CCC1)C2=NC(C3=CC=C(C=C3)C4=C5OCOC5=C(C=C4)C6=CNC([C@H]7N(CCC7)C([C@H](C(C)C)NC(OC)=O)=O)=N6)=CN2)=O)C(C)C)OC
Clinical Information
– Phase 3
Research Area
– Infection; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– HCV;HCV Protease
Pathway
– Anti-infection;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
